Related Experiment Video
Updated: Aug 11, 2026

Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease
Published on: May 10, 2024
Anti-aging gene Klotho ameliorates diabetic nephropathy in mice by inhibiting FGF2 signaling pathway
1Kidney Disease and Dialysis Center, Shaanxi Provincial People's Hospital, Xi'an, China.
Abstract:
The aim of this study was to observe the expression of Klotho in renal tissues of mice with diabetic ne¬phropathy (DN), and to further explore the effect of Klotho on DN in mice and its mechanism. The 10-week-old mice in this experiment were divided into three groups: heterozygous db/+ mouse group (db/+ group, n=20), homozygous db/db mouse group (db/db group, n=20) and homozygous db/db mice + Klotho group (db/db + Klotho group, n=20). Firstly, Western blotting and immunohistochemical staining were applied to detect the protein expression of Klotho in the renal tissues of diabetic and non-diabetic mice of different ages. Finally, the protein expressions of fibroblast growth factor 2 (FGF2) and E-cadherin in the renal tissues of mice in each group were examined by Western blotting. The protein expression level of Klotho in the renal tissues of mice aged 10 and 16 weeks in the db/db group was remarkably lower than that in yhedb/+ group. In addition, it was found that db/db + Klotho group exhibited a prominently lower degree of interstitial fi¬brosis and content of Collagen I and Collagen III in the renal tissues than db/db group. Furthermore, it was revealed that the overexpression of Klotho could significantly repress the protein expression level of FGF2 but elevate that of E-cadherin in the renal tissues of DN mice. Klotho protein may ameliorate the renal injury and fibrosis in diabetic mice by inhibiting FGF2, so it is expected to become a targeted drug for DN.
Insights
Klotho protein levels are reduced in diabetic nephropathy (DN) mouse kidneys. Supplementing Klotho ameliorates kidney fibrosis and may offer a targeted therapy for DN by inhibiting FGF2.
Area of Science:
- Nephrology
- Endocrinology
- Molecular Biology
Background:
- Diabetic nephropathy (DN) is a major complication of diabetes.
- Klotho protein plays a role in kidney health, but its function in DN is not fully understood.
Purpose of the Study:
- To investigate Klotho expression in DN mouse kidneys.
- To explore Klotho's therapeutic effects and mechanisms in DN.
Main Methods:
- Used three groups of mice: heterozygous db/+ , homozygous db/db, and db/db treated with Klotho.
- Employed Western blotting and immunohistochemical staining to analyze protein expression.
- Assessed Klotho, fibroblast growth factor 2 (FGF2), and E-cadherin levels, alongside collagen fibrosis markers.
Main Results:
- Klotho expression was significantly lower in db/db mice compared to db/+ mice.
- Klotho treatment reduced interstitial fibrosis and Collagen I/III content in db/db mice.
- Overexpressed Klotho suppressed FGF2 and elevated E-cadherin in DN mouse kidneys.
Conclusions:
- Klotho deficiency exacerbates renal injury and fibrosis in diabetic mice.
- Klotho ameliorates DN by inhibiting FGF2 and may serve as a targeted therapeutic agent.
More Related Videos
07:15Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
06:16White and Brown Adipose Grafts: An Approach to Correct Reproductive, Metabolic, and Renal Deficits in Black and Tan Brachyury (BTBR) Obese Mice
Published on: September 9, 2025